Clincosm LogoSign in Get a demo

non hodgkin lymphoma

Showing 1 - 25 of 106
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Renal Cell Carcinoma, Nasopharyngeal Carcinoma, Non Hodgkin Lymphoma Trial in United States (PRO1160)

Not yet recruiting
  • Renal Cell Carcinoma
  • +2 more
  • Detroit, Michigan
  • +4 more
Jan 31, 2023

Non Hodgkin Lymphoma, Heart; Functional Disturbance, Hodgkin Lymphoma Trial in Winston-Salem, Richmond (other, diagnostic test,

Recruiting
  • Non Hodgkin Lymphoma
  • +3 more
  • Exercise with Trainerize application
  • +5 more
  • Winston-Salem, North Carolina
  • +1 more
Feb 2, 2023

B-cell Lymphoma, Non Hodgkin Lymphoma, DLBCL Trial in Louisville (Cyclophosphamide, Fludarabine, ACE1831)

Recruiting
  • B-cell Lymphoma
  • +5 more
  • Louisville, Kentucky
    Norton Cancer Institute
Jan 24, 2023

B-cell Lymphoma, Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma Trial (BN301)

Not yet recruiting
  • B-cell Lymphoma
  • +4 more
  • (no location specified)
Nov 9, 2022

Solid Tumor, Adult, Acute Myeloid Leukemia, MDS Trial in India (AUR103)

Recruiting
  • Solid Tumor, Adult
  • +3 more
  • Surat, Gujarat, India
  • +5 more
Oct 31, 2022

Immunogenicity of COVID-19 Vaccinations in Autologous HSCT

Not yet recruiting
  • COVID-19
  • +2 more
    • Cologne, NRW, Germany
      University Hospital of Cologne
    Oct 27, 2022

    Mature B-Cell Tumor, Non Hodgkin Lymphoma, DLBCL Trial (SGR-1505)

    Not yet recruiting
    • Mature B-Cell Neoplasm
    • +25 more
    • (no location specified)
    Sep 14, 2022

    Haematological Malignancy, Acute Myeloid Leukemia, Non Hodgkin Lymphoma Trial in Worldwide (CCS1477, Pomalidomide,

    Recruiting
    • Haematological Malignancy
    • +4 more
    • Phoenix, Arizona
    • +14 more
    Aug 22, 2022

    Lymphoma, Non-Hodgkin, Relapsed Non Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma Trial in United States (CB-010,

    Recruiting
    • Lymphoma, Non-Hodgkin
    • +6 more
    • CB-010
    • +2 more
    • Scottsdale, Arizona
    • +7 more
    Aug 19, 2022

    Mycosis Fungoides of Skin (Diagnosis), Cutaneous T-cell Lymphoma, Non Hodgkin Lymphoma Trial in Cleveland (Med-Jet Injector,

    Not yet recruiting
    • Mycosis Fungoides of Skin (Diagnosis)
    • +5 more
    • Med-Jet Injector
    • +4 more
    • Cleveland, Ohio
      University Hospitals Cleveland Medical Center, Case Comprehensiv
    Aug 15, 2022

    Non Hodgkin Lymphoma, Hodgkin Lymphoma, Myeloma Trial in Tampa (CC-486, Duvelisib)

    Recruiting
    • Non Hodgkin Lymphoma
    • +3 more
    • Tampa, Florida
      Moffitt Cancer Center
    Aug 15, 2022

    Non Hodgkin Lymphoma Trial in Worldwide (Epcoritamab)

    Recruiting
    • Non Hodgkin Lymphoma
    • Palo Alto, California
    • +44 more
    Aug 12, 2022

    Colorectal Cancer, Hematologic Malignancy, Rectum Cancer Trial in Cleveland (Vactosertib, Fludarabine Phosphate,

    Not yet recruiting
    • Colorectal Cancer
    • +11 more
    • Cleveland, Ohio
      University Hospitals Cleveland Medical Center, Case Comprehensiv
    Aug 2, 2022

    Diffuse Large B Cell Lymphoma, Chronic Lymphocytic Leukemia, Non Hodgkin Lymphoma Trial in Worldwide (KRT-232, acalabrutinib)

    Recruiting
    • Diffuse Large B Cell Lymphoma
    • +2 more
    • Goshen, Indiana
    • +44 more
    Aug 3, 2022

    Hodgkin Lymphoma, Non Hodgkin Lymphoma Trial in United States (AB-205, Placebo)

    Recruiting
    • Hodgkin Lymphoma
    • Non Hodgkin Lymphoma
    • AB-205
    • Placebo
    • Duarte, California
    • +20 more
    Aug 2, 2022

    Follicular Lymphoma (FL), Non Hodgkin Lymphoma, Marginal Zone Lymphoma Trial in Worldwide (Zandelisib, Rituximab, Bendamustine)

    Recruiting
    • Follicular Lymphoma (FL)
    • +2 more
    • Tucson, Arizona
    • +134 more
    Jul 27, 2022

    Solid Tumor, Colorectal Cancer, Gastric Cancer Trial in United States (IGM-8444, FOLFIRI, Bevacizumab (and approved

    Recruiting
    • Solid Tumor
    • +8 more
    • Duarte, California
    • +9 more
    Jul 13, 2022

    Nasopharyngeal Carcinoma, Castrate Resistant Prostate Cancer, Gastric Cancer Trial in New Haven (APG-5918)

    Not yet recruiting
    • Nasopharyngeal Carcinoma
    • +8 more
    • New Haven, Connecticut
      Yale University
    Jul 8, 2022

    Improving Communication and BuildingStronger Medical Home Among

    Recruiting
    • Leukemia
    • Non Hodgkin Lymphoma
    • Interview
    • Aurora, Colorado
      Children's Hospital Colorado
    Jun 15, 2022

    Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Non Hodgkin Lymphoma Trial in Jinan (CAR-T cells)

    Recruiting
    • Relapsed Non-Hodgkin Lymphoma
    • +2 more
    • CAR-T cells
    • Jinan, Shandong, China
      The Second People's Hospital of Shandong Province
    Jun 14, 2022

    Non Hodgkin Lymphoma Trial in San Francisco (Neuropsychological testing)

    Not yet recruiting
    • Non Hodgkin Lymphoma
    • Neuropsychological testing
    • San Francisco, California
      Stanford Cancer Center
    Jun 10, 2022

    Non Hodgkin Lymphoma Trial in Cleveland (UF-KURE19 CAR-T cells, Fludarabine, Cyclophosphamide)

    Not yet recruiting
    • Non Hodgkin Lymphoma
    • UF-KURE19 CAR-T cells
    • +2 more
    • Cleveland, Ohio
    • +1 more
    Jun 9, 2022

    Non Hodgkin Lymphoma Trial in Australia, United Kingdom, United States (Magrolimab, Rituximab, Gemcitabine)

    Active, not recruiting
    • Non Hodgkin Lymphoma
    • Birmingham, Alabama
    • +19 more
    Jun 8, 2022

    Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia, Non Hodgkin Lymphoma Trial in Beijing (CAR-NK-CD19 Cells)

    Recruiting
    • Acute Lymphocytic Leukemia
    • +2 more
    • CAR-NK-CD19 Cells
    • Beijing, Beijing, China
      Beijing Boren Hospital
    Jun 5, 2022

    Multiple Myeloma, Acute Myeloid Leukemia, Non Hodgkin Lymphoma Trial in United States (PRT1419)

    Active, not recruiting
    • Multiple Myeloma
    • +3 more
    • Denver, Colorado
    • +4 more
    May 26, 2022